$-0.07 EPS Expected for Biocept, Inc. (BIOC); Parnassus Investments Upped Alliance Data Systems Corp. (ADS) Stake By $5.06 Million

April 19, 2018 - By Migdalia James

Alliance Data Systems Corporation (NYSE:ADS) Logo

Parnassus Investments increased Alliance Data Systems Corp. (ADS) stake by 2.96% reported in 2017Q4 SEC filing. Parnassus Investments acquired 20,000 shares as Alliance Data Systems Corp. (ADS)’s stock declined 13.04%. The Parnassus Investments holds 695,000 shares with $176.17 million value, up from 675,000 last quarter. Alliance Data Systems Corp. now has $11.68 billion valuation. The stock decreased 1.39% or $2.96 during the last trading session, reaching $210.65. About 1.39M shares traded or 98.23% up from the average. Alliance Data Systems Corporation (NYSE:ADS) has declined 9.99% since April 19, 2017 and is downtrending. It has underperformed by 21.54% the S&P500.

Analysts expect Biocept, Inc. (NASDAQ:BIOC) to report $-0.07 EPS on May, 10.They anticipate $0.14 EPS change or 66.67% from last quarter’s $-0.21 EPS. After having $-0.18 EPS previously, Biocept, Inc.’s analysts see -61.11% EPS growth. The stock decreased 2.15% or $0.0053 during the last trading session, reaching $0.2415. About 603,550 shares traded. Biocept, Inc. (NASDAQ:BIOC) has declined 85.25% since April 19, 2017 and is downtrending. It has underperformed by 96.80% the S&P500.

Parnassus Investments decreased Fortive Corp. stake by 47,910 shares to 952,301 valued at $68.90 million in 2017Q4. It also reduced Dentsply Sirona Inc. stake by 114,826 shares and now owns 2.00M shares. Micron Technology Inc. (NASDAQ:MU) was reduced too.

Since February 16, 2018, it had 0 insider purchases, and 2 insider sales for $8.14 million activity. The insider Miller Melisa A sold $3.00 million. On Friday, February 16 the insider HEFFERNAN EDWARD J sold $5.14 million.

Investors sentiment is 0.93 in 2017 Q4. Its the same as in 2017Q3. It has no change, as 39 investors sold ADS shares while 176 reduced holdings. only 69 funds opened positions while 132 raised stakes. 51.81 million shares or 1.64% more from 50.97 million shares in 2017Q3 were reported. Cryder Cap Prtn Ltd Liability Partnership holds 140,071 shares or 11.44% of its portfolio. 300,901 were accumulated by Hhr Asset Mngmt Ltd Limited Liability Company. Ogorek Anthony Joseph Adv invested in 0% or 24 shares. Mountain Pacific Invest Advisers Id invested in 0.12% or 4,550 shares. 20,815 are owned by Toronto Dominion National Bank & Trust. New York-based Sg Americas Secs Llc has invested 0.02% in Alliance Data Systems Corporation (NYSE:ADS). Riverpark Advsrs Ltd Limited Liability Company accumulated 23,387 shares. Amica Pension Fund Board Of Trustees accumulated 0.27% or 9,220 shares. 15,958 are held by Gulf Intll Bancshares (Uk). Ubs Oconnor holds 10,000 shares or 0.08% of its portfolio. Nomura Asset Communications, Japan-based fund reported 6,767 shares. Arcadia Investment Management Mi owns 0.5% invested in Alliance Data Systems Corporation (NYSE:ADS) for 7,000 shares. Vaughan Nelson Investment Mgmt LP holds 171,230 shares. Delaware-based Tiverton Asset Lc has invested 0.01% in Alliance Data Systems Corporation (NYSE:ADS). Macquarie Ltd reported 1,300 shares.

Among 35 analysts covering Alliance Data Systems (NYSE:ADS), 18 have Buy rating, 3 Sell and 14 Hold. Therefore 51% are positive. Alliance Data Systems had 94 analyst reports since August 9, 2015 according to SRatingsIntel. The stock of Alliance Data Systems Corporation (NYSE:ADS) earned “Hold” rating by BMO Capital Markets on Thursday, January 25. Robert W. Baird maintained the shares of ADS in report on Wednesday, November 15 with “Hold” rating. Atlantic Securities initiated Alliance Data Systems Corporation (NYSE:ADS) on Wednesday, October 5 with “Overweight” rating. Sterne Agee CRT initiated the shares of ADS in report on Thursday, December 17 with “Buy” rating. The stock of Alliance Data Systems Corporation (NYSE:ADS) earned “Hold” rating by Susquehanna on Friday, March 9. Deutsche Bank maintained the shares of ADS in report on Sunday, August 9 with “Buy” rating. SunTrust maintained it with “Buy” rating and $310.0 target in Thursday, October 19 report. The firm earned “Neutral” rating on Friday, December 11 by Credit Suisse. As per Monday, January 8, the company rating was maintained by Robert W. Baird. Compass Point upgraded the stock to “Neutral” rating in Thursday, May 25 report.

Among 3 analysts covering Biocept Inc (NASDAQ:BIOC), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Biocept Inc had 4 analyst reports since August 19, 2015 according to SRatingsIntel. H.C. Wainwright initiated Biocept, Inc. (NASDAQ:BIOC) rating on Wednesday, August 19. H.C. Wainwright has “Buy” rating and $4 target. The stock of Biocept, Inc. (NASDAQ:BIOC) earned “Buy” rating by Roth Capital on Monday, June 6.

Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor DNA assays utilizing a standard blood sample. The company has market cap of $16.43 million. The company's cancer assays provide information to oncologists and other physicians that enable them to select personalized treatment for their patients who have been diagnosed with cancer based on molecular drivers. It currently has negative earnings. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, and melanoma.

Alliance Data Systems Corporation (NYSE:ADS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts